Read news on IND with our app.
Read more in the app
Transforming Parkinson’s disease treatment, Insilico Medicine announces IND-enabling completion for AI-empowered oral NLRP3 inhibitor ISM8969 - EurekAlert!
FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy
FDA clears IND for clinical trial testing swi - EurekAlert!
